Blogs

Previous Blogs

Compliance team speak up photo

By Susan Morris

August 26, 2020

West recognizes its responsibility to operate with integrity and to proactively identify potential misconduct. We hold ourselves accountable to the highest standards of quality, integrity and respect for our team members, our shareholders, our customers, and the patients we jointly serve.

A nurse extracting a medication from a vial into a syringe

By Daniel Bantz

June 04, 2019

It is imperative for the pharmaceutical industry to be prepared to comply with new compendia chapters as soon as they are enacted. This comprises both knowing of proposed changes as soon as announced and being well prepared to accommodate them. USP Chapter <381> is changing, and Chapters <382>, <1382> and <1381> are being created. The Pharmacopeia Forum for final comments has been published.

Elastomers, Stoppers and Plungers

By Lynn Yao

May 14, 2019

In China, the industrial and regulatory landscape has been evolving rapidly – and in particular as it relates to generic drug products. In 2015, the China State Council announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44). At this same time, a series of reforms were announced by the National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to upgrade the pharmaceutical industry by raising marketed products to international standards in terms of quality, safety and efficacy.

West Employee standing in front of the West logo sign

By West&#39;s Global Communications Team

July 05, 2018

In the next blog of our series on West’s 2017 Corporate Responsibility Report, we are focusing on Compliance and Ethics. As a company that operates in a highly regulated industry to serve billions of patients around the world, it is imperative that West conducts its business in an ethical manner – not because we have to, but because it’s the right thing to do. Read on to learn more about compliance and ethics at West as published in the 2017 Corporate Responsibility Report.

Blue West logo with Diamond

By Graham Reynolds

August 28, 2013

The U.S. Food and Drug Administration recently issued a draft guidance, “Glass Syringes for Delivering Drug and Biological Products: Technical Recommendations to Supplement International Organization for Standardization (ISO) Standard 11040-4 (Draft).” The document relates to issues encountered with glass Luer lock syringes when connecting to Luer fittings, including needles, needle-free Luer connectors, adapters and transfer units.

Blue West logo with Diamond

By Simon Cote

March 04, 2013

As the pharmaceutical industry evolves amidst changing patient needs, growing regulatory requirements and improved process understanding, West is moving forward with product improvements of its own. In addition to our continuous process and product improvements and optimizations, West is harmonizing its steam sterilizable ready-to-use (RU) product packaging material.